Lymphoma pathways
Chemo-immunotherapy regimens tailored to Hodgkin and non-Hodgkin subtypes, with PET-guided decisions when appropriate.
7 min read
Blood cancers affect the blood, bone marrow, or lymphatic system. Dr. Dhar reviews blood counts, pathology, and staging to guide personalised treatment for lymphoma, leukaemia, and multiple myeloma.

Blood cancers include leukaemias, lymphomas, and multiple myeloma. They begin in blood-forming cells or immune cells and can present with fatigue, infections, swollen nodes, bone pain, or abnormal blood counts.
Treatment may involve chemotherapy, targeted therapy, immunotherapy, steroids, or combinations — chosen based on exact subtype, genetics, and how aggressive the disease is.
Clear communication matters. These diagnoses move quickly, and families need to understand urgency, options, and what the next few weeks will look like.
Symptoms overlap with many non-cancer conditions. Abnormal blood reports or persistent symptoms deserve specialist review.
Use this to prepare for your visit — not as a self-diagnosis.
Select anything that applies — then book a visit to review reports together.
Book appointmentPlans are subtype-specific. The right protocol depends on pathology, genetics, age, and fitness.
Chemo-immunotherapy regimens tailored to Hodgkin and non-Hodgkin subtypes, with PET-guided decisions when appropriate.
Induction and consolidation strategies guided by lineage, genetics, and measurable residual disease when available.
Combinations of proteasome inhibitors, immunomodulatory drugs, antibodies, and steroids based on disease burden.
Infection prevention, transfusion support, growth factors, and symptom management alongside active therapy.
Reports are reviewed to confirm subtype and decide how quickly treatment should start.
Lymphomas usually start in lymph nodes or lymphoid tissue. Leukaemias typically arise in the bone marrow and circulate in the blood. Exact subtype determines treatment.
Some blood cancers need treatment within days; others allow more time for staging. Urgency is based on subtype, blood counts, and symptoms — your oncologist will explain the timeline.
Not always. Transplant is considered for selected high-risk or relapsed cases. Many patients are treated effectively with chemotherapy, targeted drugs, and immunotherapy alone.
Many lymphomas and some leukaemias are curable. Myeloma is often highly controllable as a chronic disease. Outcomes depend on subtype, genetics, and response to therapy.
Share a few details and the clinic team will help arrange a consultation with Dr. Dhar. Prefer to talk now? Reach the appointment desk directly.